Frontier Biotechnologies to Sell 70% of API Unit to Duo Rui Pharma for RMB 10 Million
Nanjing-based Frontier Biotechnologies Inc. is poised to divest a 70% stake in its peptide active...
Nanjing-based Frontier Biotechnologies Inc. is poised to divest a 70% stake in its peptide active...
China-based Tibet Duo Rui Pharmaceutical Co., Ltd and Nanjing Heron Pharmaceutical Science and Technology Co.,...